FOLLOW US

  • facebook
  • twitter
Mon

March 9, 2026

AstraZeneca China Obesity Drug Deal

America January 30, 2026

AstraZeneca China Obesity Drug Deal Worth Up to $18.5B

Biotechnology powerhouse AstraZeneca has inked a landmark licensing agreement with China’s CSPC Pharmaceutical Group Ltd., potentially worth $18.5 billion, aimed…

By Rihem Akkouche

Health October 19, 2024

Weight Loss Drugs Are Not Without Risks

In the United States, obesity is a major problem with longstanding ramifications. Recent CDC findings reveal that 40% of Americans…

By Gabrielle Seunagal

America June 4, 2024

Supreme Court Declines Hi-Tech Pharmaceuticals’ Appeal in $40M FTC Judgment

The U.S. Supreme Court won’t hear Hi-Tech Pharmaceuticals’ challenge to the Federal Trade Commission’s $40 million judgment against it for…

By Rochdi Rais

Health February 27, 2024

Few Americans Have Confidence in Weight Loss Drugs

In the United States, almost half of the population is obese. Some officials maintain that sedentary lifestyles and increased consumptions…

By Gabrielle Seunagal

Signup for the USA Herald
exclusive Newsletter